Author:
House Andrew A.,Wells George A.,Donnelly James G.,Nadler Steven P.,Hébert Paul C.
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Reference25 articles.
1. US Renal Data System, USRDS 1997 Annual Data Report. Table D.4. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1997
2. Moustapha A, Naso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end‐stage renal disease. Circulation1998; 97: 138–141
3. Bostom AG, Shemin D, Verhoef P et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol1997; 17: 2554–2558
4. Cressman MD, Heyka RJ, Paganini EP, O’Neil J, Skibinski CI, Hoff HF. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation1992; 86: 475–482
5. Bostom AG, Shemin D, Lapane KL et al. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case‐control study. Atherosclerosis1996; 125: 91–101
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献